Latest news
CellFiber, Tidewave Bio to Evaluate 3D Cell Culture Platform for Scalable Manufacturing - Contract PharmaContract Pharma · Thu, 06 Aug 2026 19:42:43 GMTSafely Scaling High Potency API Manufacturing - Contract PharmaContract Pharma · Thu, 06 Aug 2026 19:30:13 GMTKyverna Therapeutics and ElevateBio Sign Commercial Manufacturing Agreement for Miv-Cel - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 14:47:53 GMTPlasmid DNA Manufacturing Market Size to Hit USD 12.45 Billion by 2035 - Precedence ResearchPrecedence Research · Tue, 04 Aug 2026 07:00:00 GMTCell and gene therapy manufacturers turn to specialist automation partners - PharmaLivePharmaLive · Fri, 31 Jul 2026 13:19:33 GMTKyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel - BioInformantBioInformant · Mon, 27 Jul 2026 22:25:13 GMTBig Pharma Invests in U.S. Manufacturing - Contract PharmaContract Pharma · Mon, 27 Jul 2026 07:00:00 GMT